{ "docId": "019de073-bad9-7032-8a81-e4ebe475dedb", "docSlug": "033dbe0b064db9b5c6a8c7c8096ccb5c", "documentTitle": "Genprex | Investor Presentation Deck | 44 slides", "authorId": "genprex", "authorName": "Genprex", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2022-10-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "pageCount": 44, "prevPage": 1, "nextPage": 3, "slideType": "appendix_disclosure", "function": "other", "density": "dense", "nDataPoints": 0, "notes": null, "elementsJson": null, "metadataConfidence": 1, "imagePath": null, "slideHref": "/slides/019de073-bad9-7032-8a81-e4ebe475dedb/2", "deckHref": "/decks/019de073-bad9-7032-8a81-e4ebe475dedb", "deckJsonHref": "/decks/019de073-bad9-7032-8a81-e4ebe475dedb.json", "deckAnchorHref": "/decks/019de073-bad9-7032-8a81-e4ebe475dedb#slide-2", "components": [ { "bbox": { "h": 0.535, "w": 0.928, "x": 0.036, "y": 0.211 }, "kind": "disclaimer", "text": "Statements contained in this presentation regarding matters that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding our expected operating results, our ability to continue to obtain capital to meet our long-term liquidity needs on acceptable terms, or at all, including the additional capital which will be necessary to complete the clinical trials that we have initiated or plan to initiate, achievement of key milestones, our ability to advance the clinical development, manufacturing and commercialization of our product candidates, and the effects of our product candidates, alone and in combination with other therapies, on cancer and diabetes. Risks and uncertainties that contribute to the uncertain nature of the forward-looking statements include our ability to achieve key milestones, the timing and effect of our achieving those milestones, the effects of Fast Track Designations, and of other factors, on the clinical development, manufacturing and commercialization of our product candidates, as well as the presence and level of our product candidates' effect on cancer and diabetes, the timing of our IND filings and amendments, the timing and outcome of FDA action with respect to our IND filings and amendments, the timing and our ability to contract with clinical sites and to enroll patients in our clinical trials, including the impact of the COVID-19 pandemic on such timing, the timing and performance of our third party manufacturers and suppliers, the timing and success of our clinical trials and planned clinical trials of our product candidates, the timing and success of obtaining FDA approval of our product candidates, costs associated with developing our product candidates, and whether patents will ever be issued under patent applications filed by us or that are the subject of our license agreements or that others may be able to develop competing products that do not infringe our patent rights, such that our product candidates may not have an exclusive market position. These and other risks and uncertainties are described more fully under the caption “Risk Factors” in our annual report on form 10-K for the year ended December 31, 2021 and our other filings and reports with the United States Securities and Exchange Commission. While we believe we have identified material risks, these risks and uncertainties are not exhaustive. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible to predict all risks and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. All forward-looking statements contained in this press release speak only as of the date on which they were made. Except as required by law, we undertake no obligation to update such statements to reflect events or circumstances that exist after the date on which they were made.", "attrs": null, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "4bc77623-cae9-4630-b536-a53efa84f899", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.065, "w": 0.928, "x": 0.036, "y": 0.845 }, "kind": "disclaimer", "text": "All marks, materials and information used in this presentation are exclusively owned by Genprex, Inc., including the trademarks Genprex®, Oncoprex® and REQORSA™, with all rights reserved, with the exception of Tagrisso, Keytruda and Tarceva, which are trademarks of AstraZeneca PLC, Merck & Co and OSI Pharmaceuticals, LLC respectively. No permissions of any kind whatsoever are granted to the recipient.", "attrs": null, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "5e61da6a-74e5-4eb0-9fd9-3d414f0a5f99", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.045, "w": 0.928, "x": 0.036, "y": 0.766 }, "kind": "disclaimer", "text": "This presentation highlights basic information about our company. Because it is a summary, it does not contain all of the information you should consider before investing in our company. Further information about our company may be found in our public filings and reports with the United States Securities and Exchange Commission.", "attrs": null, "subkind": null, "toolName": null, "toolSlug": null, "confidence": null, "componentId": "9f8ae3b9-2af2-4a37-85dd-2c1c1d76caa2", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.045, "w": 0.644, "x": 0.178, "y": 0.065 }, "kind": "title", "text": "FORWARD-LOOKING STATEMENTS", "attrs": null, "subkind": "headline", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "051ef620-77dd-4830-8c5c-9fa01587b63d", "frameworkName": null, "frameworkSlug": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [], "loops": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }